Acceptance and Commitment Therapy (ACT) Tele-Counselling

NCT05385458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-03

No results posted yet for this study

Summary

A randomized 2-group controlled trial will be conducted to explore the potential effect and potential feasibility of a new Acceptance and Commitment Therapy (ACT) tele-counselling program to improve mental health services for family caregivers of persons with dementia in the province of New Brunswick in Canada. The ACT tele-counselling program was launched in January 2021 with the aim of improving access to high quality psychotherapy for family caregivers, particularly in rural areas. A target sample size of 80 participants will be recruited and randomly allocated to either the ACT program or to usual care services. Mixed methods (QUANTITATIVE + qualitative) will be used to evaluate the potential impact of the ACT program compared to usual care on participant's mental health, and to generate recommendations for the expansion and continuation of the program outside of the province.

Conditions

  • Acceptance and Commitment Therapy
  • Caregiver Burden
  • Digital Health
  • Technology
  • Mental Health
  • Psychotherapy
  • Counselling
  • Dementia

Interventions

BEHAVIORAL

ACT Intervention

Acceptance and Commitment Therapy

OTHER

Usual Care

Usual Care Services

Sponsors & Collaborators

  • Alzheimer Society of New Brunswick

    collaborator UNKNOWN
  • Mount Allison University

    collaborator UNKNOWN
  • University of Ottawa

    collaborator OTHER
  • McMaster University

    collaborator OTHER
  • McGill University

    collaborator OTHER
  • University of New Brunswick

    lead OTHER

Principal Investigators

  • Pamela Durepos, PhD · University of New Brunswick

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2023-03-25
Completion
2023-03-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05385458 on ClinicalTrials.gov